Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D04TPQ
|
|||
Former ID |
DIB012723
|
|||
Drug Name |
Aganepag isopropyl
|
|||
Synonyms |
AGN-210961
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Glaucoma/ocular hypertension [ICD-11: 9C61; ICD-9: 365] | Phase 2 | [1] | |
Company |
Allergan Inc
|
|||
Structure |
Download2D MOL |
|||
Formula |
C27H37NO4S
|
|||
Canonical SMILES |
CCCCCC(C1=CC=C(C=C1)N2C(CCC2=O)CCCC3=CC=C(S3)C(=O)OC(C)C)O
|
|||
InChI |
1S/C27H37NO4S/c1-4-5-6-10-24(29)20-11-13-22(14-12-20)28-21(15-18-26(28)30)8-7-9-23-16-17-25(33-23)27(31)32-19(2)3/h11-14,16-17,19,21,24,29H,4-10,15,18H2,1-3H3/t21-,24-/m0/s1
|
|||
InChIKey |
GKRBCKDGBDUAIQ-URXFXBBRSA-N
|
|||
CAS Number |
CAS 910562-20-8
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT01110499) Safety and Efficacy of AGN-210961 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.